From: Fat utilization and arterial hypertension in overweight/obese subjects
Variables | I RQ quartile (0,78 ± 0,01) (N= 53) | II RQ quartile (0,83 ± 0,01) (N=63) | III RQ quartile (0,87 ± 0,01) (N=48) | IV RQ quartile (0,93 ± 0,02) (N=59) | p |
---|---|---|---|---|---|
Age (years) | 53 ±13 | 52 ± 12 | 53 ± 11 | 53 ± 11 | 0,922 |
BMI | 33 ± 5 | 31 ± 5 | 31 ± 4 | 32 ± 5 | 0,053 |
RMR (kcal) | 1509 ± 252 | 1433 ± 249 | 1535 ± 251 | 1571 ± 352 | 0,051 |
WC (cm) | 106 ± 13 | 102 ± 11 | 100 ± 8 | 106 ± 14 | 0,064 |
HC (cm) | 109 ± 9 | 109 ± 10 | 106 ± 7 | 111 ± 9 | 0,160 |
Glucose (mg/dl) | 94 ± 25 | 95 ± 24 | 95 ± 21 | 102 ± 34 | 0,489 |
Creatinin (mg/dl) | 0,79 ± 0,23 | 0,76 ± 0,14 | 0,77 ± 0,2 | 0,87 ± 0,76 | 0,595 |
T Cholesterol (mg/dl) | 202 ± 45 | 205 ± 44 | 208 ± 44 | 209 ± 52 | 0,896 |
LDL (mg/dl) | 126 ± 35 | 127 ± 40 | 133 ± 41 | 129 ± 46 | 0,911 |
HDL (mg/dl) | 53 ± 17 | 52 ± 12 | 46 ± 12 | 50 ± 16 | 0,162 |
Triglyceride (mg/dl) | 120 ± 59 | 130 ± 61 | 163 ± 127 | 150 ± 83 | 0,106 |
Uric acid (mg/dl) | 5,25 ±1,10 | 5,15 ± 1,60 | 5,11 ± 1,40 | 4,95 ± 1,46 | 0,809 |
SBP (mmHg) | 123 ± 11 | 123 ± 15 | 124 ± 13 | 130 ± 16 | 0,038 |
DBP (mmHg) | 76 ± 7 | 74 ± 9 | 75 ± 9 | 79 ± 9 | 0,051 |
Prevalences (%) | |||||
Male | 41,5 | 35 | 45,8 | 41 | 0,705 |
Hypertension | 30 | 20 | 22 | 47 | 0,024 |
Diabetes Mellitus | 7,5 | 6,4 | 5,7 | 8,9 | 0,948 |
Hyperlipidemia | 54 | 54,3 | 58,3 | 54,3 | 0,976 |
Obesity | 68 | 56 | 55,3 | 69 | 0,263 |
Metabolic Syndrome | 0 | 2 | 6,7 | 5,1 | 0,665 |
Medications | 4 | 4 | 5 | 5 | 0,801 |